This is a working overview of regulatory status, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-17. Anything still debated is marked as such rather than presented as settled.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
== World War 2 == On 10 June 1940, with Italy's declaration of war on France and the United Kingdom, Calabria became involved in World War II. The civilian population immediately began to suffer from starvation and undernourishment, due to the lack of labor, low wages and inflation. Some foodstuffs were already rationed, while others, such as meat and sugar, could be found only on the black market. The large landowners took advantage, appropriating crops that were destined for storage and reselling them on the black market. Allied bombardments sapped civilian morale. On 3 September 1943, British and Canadian troops of the Eighth Army landed in Calabria in Operation Baytown, the first time that the Allies landed on the Italian mainland. Those landings were a feint and the main Allied blow came on 8 September 1943 with the landing of the American 5th Army at Salerno in Campania that was intended to cut off Mezzogiorno Axis forces. The Germans anticipated the Allies' plan, and as a consequence, relatively little fighting came in Calabria. Calabria troops mostly surrendered to the advancing British 5th Infantry Division and 1st Canadian Division; relatively few German forces were present. The main obstacle was the trail of destruction left by German combat engineers who systematically blew up bridges and destroyed roads and railroads as the Wehrmacht retreated north. On the day of the American landing, General Dwight Eisenhower announced on the radio that the Armistice of Cassibile had been signed on 3 September, ending all Italian resistance.
Evidence from the study of carbon and oxygen isotope composition of tooth enamel of equids, bovids and hippopotamids from Melka Wakena and Gadeb, interpreted as indicative of presence of montane grasslands with shrubs and aquatic habitats in Ethiopian highlands that provided recurrent access to water and vegetation to mammals (including Acheulean-making hominins) in the late Early Pleistocene, is presented by Briatico et al. (2026). Evidence from the study of the composition of Middle and Late Pleistocene small mammalian assemblages from the East European Plain, interpreted as consistent with presence of semi-arid and arid steppe habitats during the warmest and driest phases of the Pleistocene interglacials, is presented Markova, Puzachenko & Tsatskin (2026). Robu et al. (2026) reconstruct trophic relationships of Late Pleistocene mammals from cave sites in the Romanian Carpathians with and without bears on the basis of an isotopic analysis of their bones, reporting evidence of overall similar dietary behavior of the studied mammals throughout Europe during Marine Isotope Stage 3, as well as evidence of mainly herbivorous diet of cave bears that included varying levels of animal protein consumption, and interpret the dietary behavior of the studied cave bears as possibly influenced by abundance of the carnivores. Russo et al. (2026) study the composition of Pleistocene faunal assemblages from the Naame, Nahr Ibrahim and Ras el-Kelb sites (Lebanon) and tooth wear of ungulates from these sites, while Russo et al.
== Development == The peritoneum develops ultimately from the mesoderm of the trilaminar embryo. As the mesoderm differentiates, one region known as the lateral plate mesoderm splits to form two layers separated by an intraembryonic coelom. These two layers develop later into the visceral and parietal layers found in all serous cavities, including the peritoneum. As an embryo develops, the various abdominal organs grow into the abdominal cavity from structures in the abdominal wall. In this process they become enveloped in a layer of peritoneum. The growing organs "take their blood vessels with them" from the abdominal wall, and these blood vessels become covered by peritoneum, forming a mesentery. Peritoneal folds develop from the ventral and dorsal mesentery of the embryo.
The cardiovascular effort to recover from each set serves a function similar to an aerobic exercise, but this is not the same as saying that a weight training set is itself an aerobic process. Strength training is typically associated with the production of lactate, which is a limiting factor of exercise performance. Regular endurance exercise leads to adaptations in skeletal muscle which can prevent lactate levels from rising during strength training. This is mediated via activation of PGC-1alpha which alter the LDH (lactate dehydrogenase) isoenzyme complex composition and decreases the activity of the lactate generating enzyme LDHA, while increasing the activity of the lactate metabolizing enzyme LDHB.
Faure Essozimna Gnassingbé (French pronunciation: [fɔʁ esozimna ɲasiŋɡbe]; born 6 June 1966) is a Togolese politician who has led Togo since 2005, first as the fourth president until 2025 and then as president of the Council of Ministers. A member of the ruling Union for the Republic (UNIR), he is the son of the third president, Gnassingbé Eyadéma. Born in Afagnan, Gnassingbé studied in the United States and France before joining the Rally of the Togolese People (RPT) in 1990. He was appointed by his father as Minister of Equipment, Mines, Posts, and Telecommunications, serving in these roles from 2003 to 2005. Following Eyadéma's death in 2005, Gnassingbé was immediately installed as president with support from the army and was elected president of the National Assembly to further legitimise his succession. However, doubts regarding the constitutional legitimacy of the succession led to heavy regional pressure being placed on Gnassingbé, and he subsequently resigned on 25 February. He then won a controversial presidential election on 24 April, and was sworn in as president. Gnassingbé further ran for three more terms in 2010, 2015 and 2020, after a 2019 constitutional amendment which allowed him to run for two more terms. In 2024, Gnassingbé once again amended Togo's constitution, transferring most of the presidency's powers to the position of prime minister, which was officially reconstituted as "president of the Council of Ministers", nominally turning Togo from a presidential republic into a parliamentary one.
Sources: en.wikipedia.org
== Metabolism == Vicine is an inactive compound in the body. When vicine enters the body through food, it is hydrolysed by intestinal microflora to the highly reactive free radical generating aglycone divicine. Upon hydrolysis, the glucose part of the molecule is split off and that results in the reduced divicine. Divicine is then taken up in the blood through the intestinal epithelium.
=== Pancreatic and glycemic control === Semaglutide enhances the growth and proliferation of pancreatic beta cells, which are responsible for insulin production, while mitigating oxidative stress to reduce cell death (apoptosis). It achieves glycemic control primarily through a glucose-dependent mechanism: by binding to GLP-1 receptors on beta cells, it elevates intracellular levels of cyclic AMP (cAMP) and activates protein kinase A (PKA) and related signaling pathways. This cascade alters cellular energy dynamics, ultimately triggering the influx of calcium into the cell, which prompts the exocytosis (release) of insulin-containing vesicles into the bloodstream. Concurrently, semaglutide inhibits the release of glucagon from pancreatic alpha cell, which decreases glucose production by the liver (gluconeogenesis) and maintains blood sugar level stability, particularly preventing sharp spikes after meals. Beyond its direct action on the pancreas, semaglutide alleviates peripheral insulin resistance. It does this by upregulating phosphorylated IRS-1 and activating pathways (like AMPK/SIRT1) that promote the transport of the GLUT4 glucose transporter to cell membranes in muscle and adipose tissue, thereby increasing overall cellular glucose uptake.
== The leading research groups, producers and applications == One of the leading groups in academy for creating ion-trap MMS is Prof. Graham Cooks with his associate Professor Zheng Ouyang at Purdue University. They have built a series of mini mass spectrometer based on quadrupole ion trap called Mini 10, Mini 11, Mini 12. The group used Mini 10 mass spectrometer weighing 10 kg to analyze proteins, peptides and alkaloids in complex plant materials with electrospray ionization ESI and paperspray ionization. The group used low radio frequency of resonant ion ejection to increase mass range up to 17,000 Da proteins. For interfacing ESI source with MMS, a 10 cm stainless steel capillary was fabricated to transfer the ions directly into the vacuum manifold. The resulting high pressure of 20 mTorr, which is several orders of magnitude higher than that used in lab-scale mass spectrometers is compensated by using the pressure-tolerant rectilinear ion trap. One of the key component of this MMS is the commercial turbo-bump and the MS can be operated at 10−3 torr. To overcome the problem of continuous sample introduction because of the small size of the pump, the group developed a technique called discontinuous atmospheric pressure introduction (DAPI). This technique performs direct chemical analysis without sample pretreatment and enables the coupling of miniature mass spectrometers to atmospheric pressure ionization sources, including ESI, atmospheric pressure chemical ionization (APCI), and various ambient ionization sources.
=== Pharmacokinetics === When administered orally in a 70:30 molar ratio, serdexmethylphenidate/dexmethylphenidate produces a dexmethylphenidate plasma concentration profile with a time to maximum concentration Tmax of approximately 2 hours and an mean terminal elimination half-life of 11.7 hours.
Sources: en.wikipedia.org
The Importance of Iron – From IronTherapy.Org Interactive material on Iron Metabolism Archived 2016-05-29 at the Wayback Machine – From IronAtlas.com Approach to chronic anemia : https://ashpublications.org/hematology/article/2012/1/183/83845/How-to-approach-chronic-anemia Handout: Iron Deficiency Anemia – From the National Anemia Action Council NPS News 70: Iron deficiency anaemia: NPS – Better choices, Better health – From the National Prescribing Service
1 August 2024 Southport stabbing The 17-year-old suspect is named as Axel Rudakubana. He is charged with three counts of murder, ten counts of attempted murder, and one count of possession of a bladed article. As a minor, he could not initially be named; but reporting restrictions on his identity are lifted by Liverpool Crown Court. After being charged, Rudakubana is remanded in custody until a plea hearing on 25 October. Keir Starmer holds a crisis meeting with police chiefs and an emergency press conference in the wake of rioting following the murders. Starmer condemns "far-right hatred" responsible for the unrest, and announces the launch of a national violent disorder programme that will see greater cooperation between police forces to tackle violent disorder, as fears grow of a "summer of unrest" fuelled by misinformation. The Bank of England cuts the UK interest rate from 5.25% to 5%, the first interest rate cut since the start of the COVID-19 pandemic in March 2020. GPs in England vote to take industrial action by working-to-rule over a lack of funding and a decline in care, which could see GP appointments capped at 25 per day. 2 August The BBC reports that Labour has shelved £1.3bn of funding promised by the Conservatives for technology and artificial intelligence (AI) projects, including an exascale supercomputer at Edinburgh University. 2024 Summer Olympics: Team GB secures three gold medals – in rowing, equestrian, and trampoline – bringing their current total to 25 medals: nine golds, eight silvers and eight bronzes.
== Society and culture == Many societies have a system for organ donation, in which a living or deceased donor's organ are transplanted into a person with a failing organ. The transplantation of larger solid organs often requires immunosuppression to prevent organ rejection or graft-versus-host disease. There is considerable interest throughout the world in creating laboratory-grown or artificial organs.
The territorial matrix is the tissue surrounding chondrocytes (cells which produce cartilage) in cartilage. Chondrocytes are inactive cartilage cells, so they don't make cartilage components. The territorial matrix is one of three major regions of the extracellular matrix; it is surrounded by the pericellular matrix and the interterritorial region. It is mostly composed of collagen fibrils, and is hypothesized to protect cartilage cells against large mechanical stress, contributing to the resiliency of the articular cartilage. The territorial matrix plays a large role in the overall load bearing capacity and resilience of the joint structure; fibril matrix acts as a compressive barrier against compressive and shear forces. The territorial matrix is basophilic (attracts basic compounds and dyes due to its anionic/acidic nature), because there is a higher concentration of proteoglycans, so it will color darker when it's colored and viewed under a microscope. In other words, it stains metachromatically (dyes change color upon binding) due to the presence of proteoglycans (compound molecules composed of proteins and sugars).
A further effect of isotretinoin on the brain involves retinoic acid function in the hypothalamus, the hormone regulatory centre of the brain and part of the hypothalamus-pituitary-adrenal axis, a key part of the body's stress response. Other brain regions regulated by retinoic acid and potentially disrupted by isotretinoin include the frontal cortex and the striatum.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.